LanzaTech expands into nutritional protein production from CO2; pre-commercial plant by 2026, commercial by 2028

LanzaTech Global, Inc.

LanzaTech announces LanzaTech Nutritional Protein (LNP) as primary product using new microbe in gas fermentation.
Engineering phase for 0.5–1.5 tons/day pre-commercial facility expected operational in 2026.
First commercial facility (>30,000 MT/yr) targeted for 2028, targeting $1 trillion alternative protein market.
LNP has complete amino acid profile; GRAS certification for human nutrition underway.
Partnerships include U.S. Navy Research Lab for military platforms and Mattson for food prototyping.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.